June 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biomea Fusion, GE Aerospace and P&G on Tuesday.
HIGHLIGHTS
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with target price $7 |
* CVS Health CVS.N: Barclays cuts target price to $79 from $82 |
* GE Aerospace GE.N: RBC raises target price to $275 from $220 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1400 from $1200 |
* P&G PG.N: Berenberg cuts target price to $152 from $157 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Applied Digital Corp APLD.O: Needham raises target price to $12 from $10 |
* Applovin Corp APP.O: JP Morgan raises target price to $400 from $355 |
* Asgn Inc ASGN.N: Wells Fargo initiates coverage with equal weight rating; PT $56 |
* Axsome Therapeutics AXSM.O: Oppenheimer initiates coverage with outperform rating |
* Axsome Therapeutics AXSM.O: Oppenheimer initiates coverage with PT $185 |
* Badger Meter BMI.N: Raymond James initiates coverage with market perform rating |
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with overweight rating |
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with target price $7 |
* Biontech SE BNTX.O: Truist Securities raises target price to $155 from $151 |
* Block XYZ.N: Evercore ISI raises to outperform from in line; ups PT to $75 from $58 |
* Block XYZ.N: Jefferies raises target price to $75 from $70 |
* Block XYZ.N: Truist Securities raises target price to $61 from $60 |
* Blueprint Medicines Corp BPMC.O: JP Morgan cuts target price to $129 from $130 |
* Blueprint Medicines Corp BPMC.O: JP Morgan cuts to neutral from overweight |
* Blueprint Medicines Corp BPMC.O: Stephens cuts target price to $135 from $150 |
* Blueprint Medicines Corp BPMC.O: Stephens cuts to equal-weight from overweight |
* Blueprint Medicines Corp BPMC.O: TD Cowen cuts to hold from buy |
* Broadcom Inc AVGO.O: Citigroup raises target price to $276 from $210 |
* Brown-Forman Corp BFb.N: Bernstein cuts target price to $53 from $57.5 |
* Bumble Inc BMBL.O: JP Morgan cuts to underweight from neutral |
* Campbell's Co CPB.O: Bernstein cuts target price to $44 from $47 |
* Campbell's Co CPB.O: Deutsche Bank cuts target price to $35 from $39 |
* Campbell's Co CPB.O: Morgan Stanley cuts target price to $35 from $40 |
* Campbell's Co CPB.O: Piper Sandler cuts target price to $41 from $42 |
* Campbell's Co CPB.O: RBC cuts target price to $38 from $44 |
* Campbell's Co CPB.O: Stifel cuts target price to $38 from $40 |
* Camping World Holdings Inc CWH.N: Truist Securities raises PT to $20 from $16 |
* Cardinal Health Inc CAH.N: Leerink Partners raises target price to $177 from $173 |
* Cardinal Health Inc CAH.N: Wells Fargo raises target price to $179 from $136 |
* Cardinal Health Inc CAH.N: Wells Fargo raises to overweight from equal weight |
* Cencora COR.N: Wells Fargo raises target price to $337 from $274 |
* Cencora COR.N: Wells Fargo raises to overweight from equal weight |
* Centene CNC.N: Barclays cuts target price to $65 from $84 |
* Centene CNC.N: Barclays cuts to equal-weight from overweight |
* Chewy CHWY.N: Deutsche Bank raises target price to $38 from $27 |
* Ciena Corp CIEN.N: Rosenblatt Securities raises target price to $85 from $65 |
* Cigna CI.N: Barclays raises target price to $385 from $382 |
* Coherent Corp COHR.N: Citigroup raises target price to $115 from $110 |
* Crowdstrike CRWD.O: Wedbush raises target price to $525 from $475 |
* CVS Health CVS.N: Barclays cuts target price to $79 from $82 |
* Digitalbridge Group Inc DBRG.N: Truist Securities raises target price to $15 from $13 |
* Disney DIS.N: Rosenblatt Securities raises target price to $140 from $135 |
* Elevance Health Inc ELV.N: Barclays cuts target price to $480 from $522 |
* Fedex Corp FDX.N: Barclays cuts target price to $330 from $350 |
* Five Below Inc FIVE.O: Mizuho raises target price to $100 from $88 |
* Fortive Corporation FTV.N: Barclays raises target price to $86 from $84 |
* Frontdoor Inc FTDR.O: JP Morgan raises target price to $55 from $50 |
* GE Aerospace GE.N: RBC raises target price to $275 from $220 |
* Greif Inc GEF.N: Wells Fargo cuts target price to $67 from $75 |
* HCA Healthcare Inc HCA.N: Barclays raises target price to $416 from $366 |
* Humana HUM.N: Barclays cuts target price to $273 from $322 |
* Immunic Inc IMUX.O: Leerink Partners cuts target price to $4 from $6 |
* KB Home KBH.N: Wells Fargo cuts target price to $53 from $55 |
* Kinder Morgan Inc KMI.N: Stifel raises target price to $28 from $27 |
* Kymera Therapeutics Inc KYMR.O: B. Riley raises target price to $60 from $38 |
* Kymera Therapeutics Inc KYMR.O: B. Riley raises to buy from neutral |
* Kymera Therapeutics Inc KYMR.O: BofA Global Research raises PT $51 from $44 |
* Kymera Therapeutics Inc KYMR.O: BofA Global Research raises to buy from neutral |
* Kymera Therapeutics Inc KYMR.O: Citigroup raises target price to $60 from $52 |
* Kymera Therapeutics Inc KYMR.O: Guggenheim raises target price to $60 from $52 |
* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises PT to $79 from $49 |
* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises to overweight from equal-weight |
* LCI Industries LCII.N: Truist Securities raises target price to $88 from $80 |
* McKesson Corp MCK.N: Wells Fargo raises target price to $766 from $691 |
* Molina Healthcare MOH.N: Barclays cuts target price to $351 from $362 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1400 from $1200 |
* ONEOK Inc OKE.N: Barclays cuts target price to $91 from $101 |
* Oshkosh OSK.N: Truist Securities raises to buy from hold; ups PT to $127 from $93 |
* P&G PG.N: Berenberg cuts target price to $152 from $157 |
* Parsons Corp PSN.N: BofA Global Research cuts price objective to $95 from $100 |
* Patrick Industries Inc PATK.O: Truist Securities raises PT to $105 from $100 |
* Peakstone Realty Trust PKST.N: Truist Securities raises target price to $16 from $15 |
* Pennant Group Inc PNTG.O: Wells Fargo raises target price to $31 from $30 |
* Perspective Therapeutics Inc CATX.A: RBC raises target price to $16 from $15 |
* Pinterest PINS.N: JP Morgan raises to overweight from neutral; ups PT to $40 from $35 |
* Prairie Operating Co PROP.O: Citigroup initiates coverage with buy rating; PT $8 |
* Resideo Technologies Inc REZI.N: JP Morgan raises target price to $21 from $20 |
* Roblox Corp RBLX.N: JP Morgan raises target price to $100 from $80 |
* Rocket Lab USA Inc RKLB.O: Deutsche Bank raises target price to $27 from $24 |
* Roku Inc ROKU.O: JP Morgan raises target price to $85 from $75 |
* Sailpoint Inc SAIL.O: Barclays cuts target price to $23 from $27 |
* Science Applications International SAIC.O: Truist Securities cuts PT to $100 from $115 |
* Science Applications International SAIC.O: Citigroup cuts PT to $144 from $155 |
* Sun Communities Inc SUI.N: Truist Securities raises target price to $137 from $135 |
* Tenet Healthcare Inc THC.N: Barclays raises target price to $215 from $171 |
* Thor Industries Inc THO.N: Truist Securities raises target price to $78 from $72 |
* Toll Brothers Inc TOL.N: Wells Fargo cuts target price to $125 from $130 |
* Trevi Therapeutics Inc TRVI.O: Oppenheimer raises target price to $23 from $20 |
* UnitedHealth UNH.N: Barclays cuts target price to $350 from $362 |
* UnitedHealth UNH.N: Piper Sandler cuts target price to $353 from $552 |
* Uranium Energy UEC.A: BMO initiates coverage with outperform rating; PT $7.75 |
* Veeva Systems Inc VEEV.N: Mizuho raises target price to $295 from $280 |
* Vera Therapeutics Inc VERA.O: Guggenheim raises target price to $65 from $61 |
* $Vornado Realty Trust(VNO-N)$ VNO.N: Truist Securities raises target price to $38 from $37 |
* Winnebago Industries Inc WGO.N: Truist Securities raises PT to $40 from $38 |
* Woodward WWD.O: Deutsche Bank raises target price to $291 from $196 |
* Woodward WWD.O: Deutsche Bank raises to buy from hold |
* Xometry Inc XMTR.O: JP Morgan raises target price to $38 from $36 |
* Zoominfo Technologies Inc GTM.O: Jefferies cuts target price to $14 from $15 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.